Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 827.4 Thousand | 1.39 Million | 1.39 Million | - | 199.1 Thousand | - |
| Cost of Revenue | 13.66 Thousand | 6266.00 | - | 14.83 Thousand | - | 20.71 Thousand |
| Gross Profit | 813.74 Thousand | 1.38 Million | 1.39 Million | -14.83 Thousand | 199.1 Thousand | -20.71 Thousand |
| Operating Expenses | 827.4 Thousand | 24.94 Million | 14.37 Million | 16.28 Million | 4.37 Million | 7.14 Million |
| Selling, General and Administrative Expenses | 3.04 Million | 4.55 Million | 4.78 Million | 4.79 Million | 2.36 Million | 3.21 Million |
| Research and Development Expenses | 5.83 Million | 21.45 Million | 10.87 Million | 11.49 Million | 4.18 Million | 3.92 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.87 Million | 24.94 Million | 14.37 Million | 16.29 Million | 4.37 Million | 7.16 Million |
| Operating Income | - | -23.52 Million | -14.25 Million | -16.29 Million | -4.37 Million | -7.16 Million |
| Interest Expense | 1.63 Million | 1.55 Million | 69.83 Thousand | 69.83 Thousand | 12.1 Thousand | - |
| Income Tax Expense | 69.58 Thousand | 38.45 Thousand | 38.45 Thousand | -627.89 Thousand | -243.42 Thousand | -621.6 Thousand |
| Earnings before Tax | -3.71 Million | -25.07 Million | -14.32 Million | -14.95 Million | -4.33 Million | -4.95 Million |
| Net Income | -3.78 Million | -25.11 Million | -14.32 Million | -14.32 Million | -4.33 Million | -4.33 Million |
| Earnings Per Share Basic | -0.03 | -0.22 | -0.21 | -0.24 | -0.13 | -0.14 |
| Earnings Per Share Diluted | -0.03 | -0.22 | -0.21 | -0.24 | -0.13 | -0.14 |
| Weighted Average Shares Outstanding | 121.26 Million | 113.73 Million | 66.73 Million | 59.17 Million | 34.32 Million | 30.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.26 Million | 113.73 Million | 66.73 Million | 59.17 Million | 34.32 Million | 30.28 Million |
| Gross Margin | 0.98 | 1.00 | 1.00 | - | 1.00 | - |
| EBIT Margin | -9.71 | -16.91 | -10.24 | - | -21.86 | - |
| Profit Margin | -4.57 | -18.06 | -10.30 | - | -21.75 | - |
| EBITDA | -8.03 Million | -7.9 Million | -24.66 Million | -15.64 Million | -5.38 Million | -6.52 Million |
| Earnings Before Tax Margin | - | -16.92 | -10.25 | - | -21.96 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 827.4 Thousand | 11.69 Thousand | 478.39 Thousand | 337.31 Thousand | - | 334.17 Thousand |
| Cost of Revenue | 13.66 Thousand | 3219.00 | 3393.00 | 3442.00 | 3442.00 | 1625.00 |
| Gross Profit | 813.74 Thousand | 8478.00 | 475 Thousand | 333.87 Thousand | -3442.00 | 332.55 Thousand |
| Operating Expenses | 8.83 Million | 2.42 Million | 2.39 Million | 1.17 Million | 2 Million | 2.18 Million |
| Selling, General and Administrative Expenses | - | 835.69 Thousand | 622.76 Thousand | 894.66 Thousand | 1.07 Million | 1.1 Million |
| Research and Development Expenses | - | 1.58 Million | 1.77 Million | 300.3 Thousand | 986.65 Thousand | 1.33 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.85 Million | 2.42 Million | 2.39 Million | 1.17 Million | 2 Million | 2.18 Million |
| Operating Income | -8.02 Million | -2.41 Million | -1.91 Million | -1.16 Million | -2 Million | -2.18 Million |
| Interest Expense | 1.63 Million | 382.91 Thousand | 438.62 Thousand | 200.35 Thousand | 173.05 Thousand | 1.15 Million |
| Income Tax Expense | 39.86 Thousand | 8957.00 | 6089.00 | -15.18 Thousand | 10.56 Thousand | -413.00 |
| Earnings before Tax | -3.74 Million | -1.09 Million | -146.24 Thousand | -1.65 Million | -2.31 Million | -3.33 Million |
| Net Income | -3.78 Million | -1.1 Million | -152.33 Thousand | -1.63 Million | -2.32 Million | -3.33 Million |
| Earnings Per Share Basic | - | -0.01 | -0.00 | -0.01 | -0.02 | -0.03 |
| Earnings Per Share Diluted | - | -0.01 | -0.00 | -0.01 | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million | 121.26 Million |
| Gross Margin | 0.98 | 0.72 | 0.99 | 0.99 | - | 1.00 |
| EBIT Margin | - | -206.33 | -4.01 | -3.45 | - | -6.52 |
| Profit Margin | -4.57 | -94.34 | -0.32 | -4.86 | - | -9.98 |
| EBITDA | - | -2.41 Million | -1.91 Million | -1.16 Million | -2 Million | -2.17 Million |
| Earnings Before Tax Margin | -9.70 | -206.61 | -4.01 | -3.45 | - | -6.53 |
NBA
CWGYF
00781K
6407
JAKK
SMAR